141 related articles for article (PubMed ID: 3696835)
1. Cefixime: spectrum of antibacterial activity against 16,016 clinical isolates.
Barry AL; Jones RN
Pediatr Infect Dis J; 1987 Oct; 6(10):954-7. PubMed ID: 3696835
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates.
Mascellino MT; Farinelli S; Iegri F; Iona E; De Simone C
Drugs Exp Clin Res; 1998; 24(3):139-51. PubMed ID: 9825230
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of cefixime, a new oral cephalosporin.
Fass RJ; Helsel VL
Chemioterapia; 1988 Dec; 7(6):365-8. PubMed ID: 3219746
[TBL] [Abstract][Full Text] [Related]
4. [Sensitivity to cefotiam of 494 hospital bacterial strains. Determination of minimal inhibitory concentration and comparison with other beta-lactams].
Reynaud A; Desnoes M; Derriennic M; Courtieu AL
Pathol Biol (Paris); 1985 May; 33(5):313-9. PubMed ID: 3929216
[TBL] [Abstract][Full Text] [Related]
5. In vitro evaluation of ceftibuten (7432-S, SCH 39720), a novel orally administered cephalosporin.
Jones RN; Barry AL
Chemioterapia; 1988 Oct; 7(5):283-6. PubMed ID: 3147148
[TBL] [Abstract][Full Text] [Related]
6. Cefdinir: in vitro activity study and effect of human serum.
García-Rodríguez JA; Trujillano-Martín I; García-Sánchez JE
Drugs Exp Clin Res; 1993; 19(2):51-8. PubMed ID: 8223142
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of cefixime: correlation index between MIC and disc diffusion test.
Focà A; Liberto MC; Berlinghieri MC; Matera G; Puccio R; Carbone M; Fera MT
Drugs Exp Clin Res; 1990; 16(4):175-9. PubMed ID: 2076653
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
[TBL] [Abstract][Full Text] [Related]
11. [In vitro antibacterial effect of a new oral cephalosporin, cefixime. Results of a multicenter study].
Soussy CJ; Kitzis MD; Thabaut A; Chanal M; Bure A; Vergnaud M; Reynaud AE; Coulet M; Dabernat H; Muller-Serieys C
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):528-33. PubMed ID: 2508039
[TBL] [Abstract][Full Text] [Related]
12. Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations.
Jones RN; Huynh HK; Biedenbach DJ; Fritsche TR; Sader HS
J Antimicrob Chemother; 2004 Jul; 54(1):144-54. PubMed ID: 15190031
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of a new broad spectrum, beta-lactamase-stable oral cephalosporin, cefixime.
Neu HC
Pediatr Infect Dis J; 1987 Oct; 6(10):958-62. PubMed ID: 3696836
[TBL] [Abstract][Full Text] [Related]
14. [In vitro antibacterial activity of cefmenoxime (SCE 1365)].
Brun Y; Forey F; Coulet M; Fleurette J; Bryskier A
Pathol Biol (Paris); 1983 May; 31(5):343-6. PubMed ID: 6312394
[TBL] [Abstract][Full Text] [Related]
15. Cefpodoxime: comparative antibacterial activity, influence of growth conditions, and bactericidal activity.
Knothe H; Shah PM; Eckardt O
Infection; 1991; 19(5):370-6. PubMed ID: 1800379
[TBL] [Abstract][Full Text] [Related]
16. [In vitro activity of a new 3d-generation cephalosporin, cefodizime, on hospital bacteria].
Soussy CJ; Otterbein G; Le Van Thoi J; Duval J; Chanal M; Cluzel M; Sirot D
Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):561-6. PubMed ID: 3534743
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of temocillin, moxalactam and cefotaxime against gram negative bacteria sensitive or resistant to ureidopenicillins and/or cefacedone.
Bartmann K; Tarbuc R
Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Dec; 256(2):202-10. PubMed ID: 6324518
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial activity of the investigational oral and parenteral cephalosporin BK-218.
Johnson DM; Jones RN
Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):181-8. PubMed ID: 1396735
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro activity of cefixime, cefaclor and loracarbef against urinary pathogens.
Hamilton-Miller JM; Brumfitt W
Drugs Exp Clin Res; 1991; 17(10-11):517-9. PubMed ID: 1841042
[TBL] [Abstract][Full Text] [Related]
20. Cefotaxime: a review of in vitro antimicrobial properties and spectrum of activity.
Jones RN; Thornsberry C
Rev Infect Dis; 1982; 4 Suppl():S300-15. PubMed ID: 6294779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
